Pacific Biosciences of California Inc (NASDAQ:PACB)
| 4.57 Delayed Data As of Jun 29 |  -0.29 / -5.97%Today’s Change | 3.85 Today|||52-Week Range 36.36 | -77.66% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Operating Activities | Net Income / Starting Line | -31.7M | -74.4M | -92.2M | -102.6M | |
| Depreciation | 3.7M | 3.9M | 8.4M | 7.2M | ||
| Total Other Cash Flow | 11.5M | 20.6M | 22.3M | 23.3M | ||
| Funds From Operations | -16.5M | -49.9M | -61.5M | -72.1M | ||
| Funds From/For Other Operating Expenses | 31.4M | 18.0M | 6.0M | -5.7M | ||
| Net Cash Flow - Operating Activities | -47.9M | -67.9M | -67.5M | -66.4M | ||
| Investing | Increase In Investments | -89.1M | -95.8M | -86.3M | -122.2M | |
| Decrease In Investments | 100.7M | 89.2M | 95.2M | 85.6M | ||
| Capital Expenditures | -3.0M | -8.2M | -10.4M | -1.9M | ||
| Fixed Asset Disposal | 36.0K | 10.0K | 41.0K | 0.00 | ||
| Net Cash Flow Investing | 8.6M | -14.9M | -1.5M | -38.4M | ||
| Financing | Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Long Term Debt Reduction | 0.00 | 0.00 | -4.5M | 0.00 | ||
| Net Proceeds Stock Sale | 36.5M | 65.9M | 73.3M | 107.2M | ||
| Common Preferred Redeemed | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Dividends | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Cash Dividends Paid - Total | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Sources - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Uses - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Net Cash Flow - Financing | 36.5M | 65.9M | 68.8M | 107.2M | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -- | -- | -- | -- | -- |
| Net Change In Cash | -2.8M | -16.9M | -258.0K | 2.3M | ||
